Athenex, Inc.
Athenex, Inc. (ATNX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATNX · as of Jun 9, 2026
Key Statistics
Explore Athenex, Inc. Data
atnx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 50.0%
Competitors & Peers
atnx competitorsATNX
CUTR
EIGRQ
FRES
HIND
NTBLStock Performance
Full HistoryAbout Athenex, Inc.
Athenex, Inc. is a biopharmaceutical company primarily dedicated to the discovery, advancement, and commercialization of therapeutic agents for oncological conditions. Its operations are structured ac…
what is athenex, inc. · atnx stock overview · athenex, inc. company profile · who is athenex, inc. ceo · atnx NASDAQ · athenex, inc. headquarters · athenex, inc. business segments
About Stock Overview & Key Data
Athenex, Inc. (ATNX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jun 14, 2017. As of the latest trading session, ATNX stock price is $0.20, with a market capitalization of $2.3M. The stock has returned -98.12% over the past 12 months and -94.16% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Athenex, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Athenex, Inc. reported revenue of $102.8M and net income of -$99.0M. For detailed data — including Athenex, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Athenex, Inc. (ATNX) stock price is $0.20. The stock is traded on NASDAQ under the ticker symbol ATNX. The 52-week range is $0.08 – $23.80.